The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum
- 1 October 1999
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 46 (1) , 35-41
- https://doi.org/10.1016/s0168-8227(99)00063-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.Journal of Clinical Investigation, 1997
- The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)Biochimie, 1997
- Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lipoprotein lipase mass and activity in severe hypertriglyceridemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM SubjectsDiabetes Care, 1992
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- Low-density lipoprotein subclass patterns and risk of myocardial infarctionJAMA, 1988
- Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Lipolytic Enzymes and Plasma Lipoprotein MetabolismAnnual Review of Biochemistry, 1980